Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.18 | -22.01 |
PEG Ratio (TTM) | 0.02 | 15.69 |
P/S Ratio (TTM) | 1.21 | 48.43 |
P/B Ratio (TTM) | 1.38 | 18.71 |
P/FCF Ratio (TTM) | -6.07 | -2.79 |
Price to 5YR AVG Earnings Ratio | N/A | -3.21 |
Price to 5YR AVG FCF Ratio | N/A | -8.75 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -49.94% | -5.02% |
ROE (TTM) | -46.15% | 16.95% |
Net Profit Margin (TTM) | -55.52% | -1,552.13% |
ROIC 5YR AVG | N/A | 14.51% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -659.36% | -130.77% | N/A |
Revenue | -27.31% | 2,529.81% | N/A |
Net Income | -663.71% | -141.45% | N/A |
Cash Flow | -3,354.26% | -162.56% | N/A |
Health (51%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.66 | 6.08 |
Quick Ratio (TTM) | 4.66 | 5.80 |
D/E Ratio (TTM) | 0.01 | -15.32 |
Interest Coverage (TTM) | -44.82 | -1.96 |
Piotroski F-Score | 6 | 5 |
Altman Z-Score | 1.22 | 13.86 |
LTL to 5YR AVG FCF | N/A | 0.16 |
Shares Outstanding Growth 5YR AVG | N/A | 128.58% |